Male genitalia development

pathway activity — cross-omics
GO:0030539Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Male genitalia development pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are THEMIS2, AR, and MMP11, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Male genitalia development activity versus THEMIS2 in OV (Pearson r = -0.17).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVTHEMIS2 →-0.578-0.557.008.00125
BRCAAR →+1.914+0.352<.001<.00134
BRCAMMP11 →+1.369+0.362<.001.00134
BRCAHTR7P1 →+1.047+0.603<.001<.00134
BRCAPRDM6 →+0.534+0.381<.001.00234
LSCCCFAP69 →+0.342+0.432.004<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0030539 vs THEMIS2 — OV

Per-sample scatter of Male genitalia development activity vs THEMIS2 in OV.

Explore this scatter interactively →

Exploration